Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.41 USD | +0.32% | +0.21% | -2.99% |
May. 22 | Enfusion Insider Sold Shares Worth $325,263, According to a Recent SEC Filing | MT |
May. 09 | Enfusion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 205M | Sales 2025 * | 243M | Capitalization | 865M |
---|---|---|---|---|---|
Net income 2024 * | 12M | Net income 2025 * | 24M | EV / Sales 2024 * | 3.95 x |
Net cash position 2024 * | 54.12M | Net cash position 2025 * | 91.23M | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
124
x | P/E ratio 2025 * |
55.9
x | Employees | 1,102 |
Yield 2024 * |
0.05% | Yield 2025 * |
-
| Free-Float | 66.3% |
Latest transcript on Enfusion, Inc.
1 day | +0.32% | ||
1 week | +0.21% | ||
1 month | -1.05% | ||
3 months | +8.54% | ||
6 months | -6.83% | ||
Current year | -2.99% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 64 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 9.41 | +0.32% | 389,223 |
24-05-30 | 9.38 | -1.16% | 259,765 |
24-05-29 | 9.49 | -1.35% | 278,899 |
24-05-28 | 9.62 | +2.45% | 574,499 |
24-05-24 | 9.39 | +0.97% | 193,344 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.99% | 865M | |
+8.91% | 85.92B | |
+5.14% | 77.91B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |
- Stock Market
- Equities
- ENFN Stock